“Treatment for endometrial cancer typically involves surgery and may be followed by radiation therapy, chemotherapy or hormone therapy, depending on the stage and characteristics of the cancer ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

Surgery is the cornerstone of treatment for uterine (endometrial) cancer at Memorial Sloan Kettering. For many women, it’s used for removing the cancer as well as diagnosis and staging information.

[45–48] A meta-analysis of these concluded that pelvic external beam radiotherapy (EBRT) after surgery for endometrial cancer reduced pelvic recurrence in stage I cancer but did not improve ...

—A new study from California-based researchers reports that things may be getting worse for certain women at risk for endometrial cancer. Here’s what the research team adds to what’s known ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, registrational-intent, multicenter Phase 2b trial of ACR-368 in ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...

At the ASCO 2024, four clinically very important abstracts in endometrial cancer were presented. Long-term survival for ...

Miller in a contextual supplement published with the study. Researchers enrolled 842 patients with stage 3 to 4 or recurrent endometrial cancer with no previous chemotherapy or disease progression at ...

Laparoscopic surgery for stage I endometrial cancer produces better short-term outcomes and fewer severe postoperative complications than open hysterectomy. Survival data from a large randomized ...